ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
Su Chul Jang et al. develop exoSTING, consisting of an engineered extracellular vesicle loaded with a potent cyclic dinucleotide (CDN) agonist of the STING pathway. They find that exoSTING shows more than 100-fold increased potency in in vivo tumor models and has increased tumor retention and lower...
Guardado en:
Autores principales: | Su Chul Jang, Kyriakos D. Economides, Raymond J. Moniz, Chang Ling Sia, Nuruddeen Lewis, Christine McCoy, Tong Zi, Kelvin Zhang, Rane A. Harrison, Joanne Lim, Joyoti Dey, Marc Grenley, Katherine Kirwin, Nikki L. Ross, Raymond Bourdeau, Agata Villiger-Oberbek, Scott Estes, Ke Xu, Jorge Sanchez-Salazar, Kevin Dooley, William K. Dahlberg, Douglas E. Williams, Sriram Sathyanarayanan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d6164d29cedd4b8db922002838b3e600 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
STING Signaling and Skin Cancers
por: Sayaka Sato, et al.
Publicado: (2021) -
Management of corneal bee sting
por: Razmjoo H, et al.
Publicado: (2011) -
Stinging Trichomes in Apocynaceae and Their Evolution in Angiosperms
por: Maria Camila Medina, et al.
Publicado: (2021) -
Activation of STING requires palmitoylation at the Golgi
por: Kojiro Mukai, et al.
Publicado: (2016) -
Signalling strength determines proapoptotic functions of STING
por: Muhammet F. Gulen, et al.
Publicado: (2017)